At Novartis, we innovate, develop and operate on a vast scale. You can be part of it. Join our creative community of professionals and you will find opportunities to make an unprecedented impact – on ...

Swiss drugmaker Novartis plans a $23 billion investment in building and expanding 10 manufacturing and research facilities in the U.S. This move aligns with their U.S.-first strategy amid looming ...

(Reuters) - Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 facilities in the U.S., as it grapples with renewed threats of drug import duties from ...

(Reuters) - Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 facilities in the U.S., as it grapples with renewed threats of drug import duties from the ...

Novartis’ expansion will substantially boost its capital spending, which has run around $1 billion the past several years. It will also broaden Novartis’ commercial footprint, adding six new ...

The Novartis Gene Therapies manufacturing facility on Tricenter Blvd. in Durham, N.C., just outside Research Triangle Park. Brian Gordon Swiss pharmaceutical giant Novartis has exited one of its ...

North Carolina economic development officials have terminated an economic incentives agreement for Novartis Gene Therapies, which hasn’t met hiring targets tied to a package that promised up to ...

Novartis announced the appointment of a new chief legal and compliance officer on Monday morning, following the departure of Klaus Moosmayer, who currently serves as chief ethics, risk and compliance ...

No­var­tis’ prostate can­cer ra­dio­phar­ma­ceu­ti­cal Plu­vic­to has net­ted a high­ly an­tic­i­pat­ed and high­ly de­layed ex­pand­ed in­di­ca­tion.